about
Broad-spectrum antiviral therapeuticsToscana virus NSs protein inhibits the induction of type I interferon by interacting with RIG-IInhibition of the type I interferon response in human dendritic cells by dengue virus infection requires a catalytically active NS2B3 complexSuppression of the interferon and NF-κB responses by severe fever with thrombocytopenia syndrome virus.Combination antiretroviral therapy (cART) restores HIV-1 infection-mediated impairment of JAK-STAT signaling pathway.FAS-associated factor-1 positively regulates type I interferon response to RNA virus infection by targeting NLRX1.Respiratory syncytial virus interferon antagonist NS1 protein suppresses and skews the human T lymphocyte responsePorcine type I interferons: polymorphic sequences and activity against PRRSV.Human metapneumovirus inhibits IFN-β signaling by downregulating Jak1 and Tyk2 cellular levels.Tick-borne encephalitis virus delays interferon induction and hides its double-stranded RNA in intracellular membrane vesicles.Interferon antagonist NSs of La Crosse virus triggers a DNA damage response-like degradation of transcribing RNA polymerase II.Nonstructural Protein 11 of Porcine Reproductive and Respiratory Syndrome Virus Suppresses Both MAVS and RIG-I Expression as One of the Mechanisms to Antagonize Type I Interferon Production.An overlapping protein-coding region in influenza A virus segment 3 modulates the host responseCellular La protein shields nonsegmented negative-strand RNA viral leader RNA from RIG-I and enhances virus growth by diverse mechanisms.Neuroimmunology of central nervous system viral infections: the cells, molecules and mechanisms involved.Age-related gene expression in Tourette syndrome.Non-cytotoxic antiviral activities of granzymes in the context of the immune antiviral state.Herpesviral infection and Toll-like receptor 2BamHI-A rightward frame 1, an Epstein-Barr virus-encoded oncogene and immune modulator.HCV innate immune responses.Bunyaviruses and the type I interferon system.Response of Three Different Viruses to Interferon Priming and Dithiothreitol Treatment of Avian Cells.Cell entry of lymphocytic choriomeningitis virus is restricted in myotubes.NSs protein of rift valley fever virus induces the specific degradation of the double-stranded RNA-dependent protein kinase.Severe acute respiratory syndrome coronavirus evades antiviral signaling: role of nsp1 and rational design of an attenuated strain.Comparison of antiviral activity of recombinant and natural interferons against crimean-congo hemorrhagic Fever virus.A Kaposi's sarcoma-associated herpesvirus protein that forms inhibitory complexes with type I interferon receptor subunits, Jak and STAT proteins, and blocks interferon-mediated signal transduction.Vaccinia virus-mediated inhibition of type I interferon responses is a multifactorial process involving the soluble type I interferon receptor B18 and intracellular componentsRespiratory syncytial virus nonstructural proteins decrease levels of multiple members of the cellular interferon pathways.Innate immune modulation in EBV infection.
P2860
Q21135293-1C288679-A07D-468C-95E0-62FBD248456FQ24337813-19E243F7-B866-4A8E-9582-3CA723ECC6C5Q24611465-01105D2E-4D2E-4305-9D99-8E4E8D6FE178Q33401401-B6F1F3F6-918B-4AD4-87FA-1CD20E31E32BQ33618390-1CAAF7EE-A037-4E1E-A7E6-95F886C8313AQ33758017-A438D9FF-3BAD-42C4-8F8B-3B5820FD4E25Q33886159-1D241209-8636-4AA4-AAB2-3B697485E3DFQ33924457-D7713307-16AF-46B1-95D9-C411D33ABE10Q34031372-5834216F-98F6-418D-9882-195D4D16B5EFQ34055431-EAEA86E3-1316-4021-A998-658F711AE62BQ34536954-296C60D3-9590-4BBF-B661-8F2085579D64Q36229509-26076D63-E8C5-4E7B-BFC6-540A6E1EF291Q36554219-74B525A3-FA0B-4A82-B141-1C9E2B5EFF72Q36845620-F3765070-508A-45E7-B67F-507107CDC5EAQ37037317-964B18C3-AF03-4715-8834-EA57511F5AD2Q37142893-DBDB5558-E8F7-4CD6-AA49-13D458D51EF0Q37763996-FF5614CC-2F7D-4D0C-8D83-9BA842373A51Q38032237-348E6C85-3A32-42C7-8A23-7B0C39399DBCQ38133428-D06977EC-DF4D-4CC8-A251-23D6B5FB1769Q38613608-FDC6FDF2-EB06-4288-83B9-0A765E43F887Q38613824-382FC95B-876C-4EFB-A2AE-D43FF697C81AQ38756727-2815C79E-0366-4089-9CEC-5363BC46ED0DQ38985001-1A9435DA-79A1-478D-817D-6AF076DB0A16Q39195523-68BF9C83-B724-4ACF-8B97-BF813A3D2054Q40090304-2DC21EC7-65DB-4F89-8ED9-FABA21296121Q40357292-D9BFC453-690F-4FD5-85CD-D7DE54E8083CQ41898857-E637B12A-ACAA-46BE-A7D1-48B3AAED2CADQ42093151-E896F316-C62A-489B-A8E1-08A80FF0FB15Q42207575-9F3E07B3-A423-4020-839C-ACEBD3B76981Q42702857-26046316-B81E-4755-88BE-79AB2E3E6AA6
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Viral suppression of the interferon system.
@en
type
label
Viral suppression of the interferon system.
@en
prefLabel
Viral suppression of the interferon system.
@en
P1433
P1476
Viral suppression of the interferon system.
@en
P2093
Otto Haller
P304
P356
10.1016/J.BIOCHI.2007.01.005
P577
2007-01-27T00:00:00Z